Watson loses naproxen case; infringement deemed willful
IPBiz (Free subscription) | 14/08/2008
The Biloxi Sun Herald reported that on August 13 SD Fl found that Andrx's Naproxen Sodium ER tablets infringe Patent No. 5,637,320 of Elan and that Andrx's infringement was willful. The Florida district court set a later date for discussion of damages. Watson/(Andrx) intends to appeal the ruling. The case has a long history. On May 5, 2004, the United States Court of Appeals for the Federal Circuit...
- Watson Announces District Court Ruling in Naproxen Sodium Patent Suit - The Earth Times Online Newspaper
- Watson Announces District Court Ruling in Naproxen Sodium Patent Suit - PR News Wire















